Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study

scientific article

Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/OBY.20248
P932PMC publication ID4170589
P698PubMed publication ID23505187
P5875ResearchGate publication ID236057683

P2093author name stringKeri L Monda
Patrick T Bradshaw
June Stevens
P2860cites workImpact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemiaQ24645182
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)Q27860959
Banting lecture 1988. Role of insulin resistance in human diseaseQ29547283
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationQ29547453
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigatorsQ29614947
Reproducibility and validity of a semiquantitative food frequency questionnaireQ29615669
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionQ29615691
What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?Q32130439
Insulin resistance syndrome, body mass index and the risk of ischemic heart diseaseQ33938941
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studiesQ34170210
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes FederationQ34567335
Identification and characterization of metabolically benign obesity in humansQ34807153
"Sick fat," metabolic disease, and atherosclerosisQ34911019
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; InternatQ35006662
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.Q35135723
What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndromeQ35780390
Metabolic and body composition factors in subgroups of obesity: what do we know?Q35794449
Modest exercise prevents the progressive disease associated with physical inactivityQ36702669
Exercise, abdominal obesity, skeletal muscle, and metabolic risk: evidence for a dose responseQ37145972
Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities StudyQ37297874
Healthy obesityQ37498152
The distinction of metabolically 'healthy' from 'unhealthy' obese individualsQ37633348
High adiponectin concentrations are associated with the metabolically healthy obese phenotypeQ38288536
How smoking affects blood pressureQ41480375
Smoking combined with overweight or obesity markedly elevates cardiovascular risk factorsQ43717535
Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men.Q45019045
Can we identify metabolically healthy but obese individuals (MHO)?Q45239119
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).Q46434824
The metabolically healthy but obese individual presents a favorable inflammation profileQ46458620
Prevalence of uncomplicated obesity in an Italian obese populationQ46564753
Metabolically healthy but obese women: effect of an energy-restricted dietQ46574442
The metabolically obese, normal-weight individual revisitedQ47289395
Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in TaiwanQ47898010
Duration of overweight and metabolic health risk in American men and women.Q51527756
Comment on the provisional report from the WHO consultationQ62127032
A short questionnaire for the measurement of habitual physical activity in epidemiological studiesQ70501617
Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activityQ70870281
American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DCQ73188683
P433issue1
P921main subjectobesityQ12174
metabolic syndromeQ657193
atherosclerosisQ12252367
P304page(s)203-209
P577publication date2013-01-01
P1433published inObesityQ15763232
P1476titleMetabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study
P478volume21

Reverse relations

cites work (P2860)
Q93159765Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study)
Q34388666Association between leisure time physical activity and metabolic syndrome: a meta-analysis of prospective cohort studies
Q40147068Association of meat and dairy consumption with normal weight metabolic obesity in men: the Qazvin Metabolic Diseases Study.
Q36125813Associations of sitting time and occupation with metabolic syndrome in South Korean adults: a cross-sectional study
Q92431691CORRELATION BETWEEN THE WAIST CIRCUMFERENCE, DIASTOLIC BLOOD PRESSURE AND INSULIN RESISTANCE IN NON-OBESE YOUNG ADULTS
Q27331844Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies
Q35814763Differences in physical activity domains, guideline adherence, and weight history between metabolically healthy and metabolically abnormal obese adults: a cross-sectional study
Q48325238Distribution and related factors of cardiometabolic disease stage based on body mass index level in Chinese adults-The National Diabetes and Metabolic Disorders Survey.
Q37718667Do rapid BMI growth in childhood and early-onset obesity offer cardiometabolic protection to obese adults in mid-life? Analysis of a longitudinal cohort study of Danish men
Q50003545Evidence of genetic predisposition for metabolically healthy obesity and metabolically obese normal weight
Q44971810Excess body weight affects HbA1c progression irrespective of baseline HbA1c levels in Japanese individuals: a longitudinal retrospective study
Q34534176Gender-specific genetic associations of polymorphisms in ACE, AKR1C2, FTO and MMP2 with weight gain over a 10-year period
Q37602772Healthy obese persons: how can they be identified and do metabolic profiles stratify risk?
Q48097260Hormetic effect of triiodothyronine in metabolically healthy obese persons
Q46903687Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study
Q35832628Interaction of smoking and obesity susceptibility loci on adolescent BMI: The National Longitudinal Study of Adolescent to Adult Health
Q36197446Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype
Q64098666Is normal body mass index a good indicator of metabolic health in Azar cohort population?
Q39941906Leisure-time exercise, physical activity during work and commuting, and risk of metabolic syndrome
Q91174480Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension
Q38507577Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes
Q52821582Mass spectrometry based metabolomics: a novel analytical technique for detecting metabolic syndrome?
Q35911623Metabolic Syndrome and Importance of Associated Variables in Children and Adolescents in Guabiruba - SC, Brazil.
Q36570776Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients
Q40538681Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women
Q37700261Metabolic syndrome among non-obese adults in the teaching profession in Melaka, Malaysia
Q92714560MiR-30a-5p accelerates adipogenesis by negatively regulating Sirtuin 1
Q55108866Mind-Body Therapies for African-American Women at Risk for Cardiometabolic Disease: A Systematic Review.
Q92692917OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions
Q44664490Obesity Paradox should not interfere with public health efforts
Q36964652Obesity and Hypertension in Association with Diastolic Dysfunction Could Reduce Exercise Capacity
Q42271438Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.
Q90060498Obesity subtypes, related biomarkers & heterogeneity
Q91557450Obesity without metabolic disorder and silent brain infarcts in aneurologically healthy population
Q47897655Obesity, metabolic abnormality, and health-related quality of life by gender: a cross-sectional study in Korean adults
Q41618593Pediatric metabolic syndrome: from prevention to treatment
Q49834355Phenotypes of Obesity: How it Impacts Management
Q94452933Prevalence of Metabolic Syndrome and Its Association with Sociodemographic Characteristics in Participants of a Public Chronic Disease Control Program in Medellin, Colombia, in 2018
Q36388059Prevalence of Metabolic Syndrome in Elementary School Children in East of Iran
Q40924423Prevalent hyperglycemia in older obese population and age-dependent convergence of obese indices: Results of a cross-sectional study of Japanese generations over the adult life span
Q35354053Subclinical atherosclerosis and obesity phenotypes among Mexican Americans
Q34071040Sugar-sweetened beverages and prevalence of the metabolically abnormal phenotype in the Framingham Heart Study
Q38667159The effects of high intensity interval training on muscle size and quality in overweight and obese adults
Q45123457The metabolically healthy overweight and obese and their impact on all-cause mortality.
Q47144826The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article
Q41078925Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: the atherosclerosis risk in communities study
Q100559740Visceral adiposity index is associated with silent brain infarct in a healthy population
Q36321416Weight loss therapy for clinical management of patients with some atherosclerotic diseases: a randomized clinical trial

Search more.